Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On November 10, 2025, Skye Bioscience, Inc. (the “Company” or “Skye”) issued a press release providing a corporat
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated November 10 , 2 025 104 Cover Page Interactive Data File (embe